Alan W. Dunton

Alan W. Dunton is the current Director at Oragenics. Prior to this, they served as Senior Vice President of Research and Development at Purdue Pharma from November 2015 to March 2018. Alan was also a member of the Executive Committee. Before Purdue Pharma, they were the Non-Executive Chairman of the Board at EpiCept Corporation from January 2012 to January 2013, during which time the company merged with IMMUNE. From January 2012 to November 2015, Dunton was also a Director at Sancilio & Company. Alan has also served as Director at Palatin Technologies and Oragenics, Inc. In addition, they were President and CEO at Panacos Pharmaceuticals, Inc. from January 2007 to March 2009, and Director at MediciNova, Inc. from September 2006 to January 2011. From June 2006 to August 2015, Dunton was also Principal and Founder at Danerius, LLC.

Alan W. Dunton earned their M.D. from New York University School of Medicine and is certified by the American Board of Internal Medicine. Alan currently works as a doctor in internal medicine in New York.